Home

Marksans Pharma Ltd Quarterly Result

Image

Marksans Pharma Ltd

NSE: MARKSANS

Net Profit - Last Quarter

₹ 97.76 Cr.

Last updated on: Jan 08, 2025

Key Highlights

  • The revenue of Marksans Pharma Ltd for the Sep '24 is ₹ 652.98 crore as compare to the Jun '24 revenue of ₹ 605.57 crore. This represent the growth of 7.828983%.
  • The ebitda of Marksans Pharma Ltd for the Sep '24 is ₹ 146.74 crore as compare to the Jun '24 ebitda of ₹ 143.39 crore. This represent the growth of 2.33629%.
  • The net profit of Marksans Pharma Ltd for the Sep '24 is ₹ 97.76 crore as compare to the Jun '24 net profit of ₹ 89.07 crore. This represent the growth of 9.756374%.

Results Analysis

Market Price of Marksans Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
08 Jan 2025283.4
07 Jan 2025289.5
06 Jan 2025285.35
03 Jan 2025297.55
02 Jan 2025298
01 Jan 2025304.7
31 Dec 2024296.7
30 Dec 2024287.35
27 Dec 2024293.6
26 Dec 2024290.15

Historical Revenue of Marksans Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Marksans Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Marksans Pharma Ltd

No data available

* All values are in crore

Marksans Pharma Ltd News Hub

Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketing Authoriz

Read more

2024-08-21 00:00:00

Marksans Pharma gets EIR from USFDA for Goa facility

The inspection has been classified as voluntary action indicated (VAI) and has been closed according

Read more

2024-08-20 00:00:00

Marksans Pharma's Verna unit successfully completes USFDA inspection

Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR) for its

Read more

2024-08-20 00:00:00

Marksans Pharma to convene AGM

Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be held on 24 Se

Read more

2024-08-20 00:00:00

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Marksans Pharma Ltd

What key financial metrics are included in Marksans Pharma Ltd's quarterly results?

Key financial metrics in Marksans Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Marksans Pharma Ltd announce its quarterly results?

Marksans Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Marksans Pharma Ltd's quarterly performance impact its stock price?

Marksans Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Marksans Pharma Ltd's quarterly results on dividends?

The impact of Marksans Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Marksans Pharma Ltd's quarterly results?

Yes, Marksans Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions